Compare Stocks

→ The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EARS Auris Medical	$1.44 -8.9%	$2.88	$0.73 ▼ $6.60	$16.44M	1.17	3.10 million shs	2.98 million shs
MNK Mallinckrodt	$0.12	$0.34	$0.75 ▼ $6.42	$1.58M	N/A	2.62 million shs	39,227 shs
OHRP OHR Pharmaceutical	$0.42	$7.37	$1.60 ▼ $6.28	$1.19M	0.84	180,228 shs	21,218 shs
SXTC China SXT Pharmaceuticals	$1.07	$1.74	$0.94 ▼ $9.38	$492K	1	1.05 million shs	381,681 shs
XTLB XTL Biopharmaceuticals	$2.56 -1.2%	$3.99	$1.73 ▼ $6.69	$13.95M	1.21	200,233 shs	33,017 shs

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EARS Auris Medical	-8.86%	-2.70%	-16.76%	-36.84%	+34.58%
MNK Mallinckrodt	0.00%	0.00%	0.00%	0.00%	-97.99%
OHRP OHR Pharmaceutical	0.00%	+0.26%	-57.90%	-30.07%	+197.53%
SXTC China SXT Pharmaceuticals	0.00%	-9.32%	-37.79%	-43.68%	-77.71%
XTLB XTL Biopharmaceuticals	-1.16%	+3.64%	-8.90%	+212.20%	+109.82%

At first glance, this chart looks like nonsense… (Ad)

We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”

But if you want the stock with “Hotspot Dates” hitting NEXT WEEK…

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EARS Auris Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MNK Mallinckrodt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OHRP OHR Pharmaceutical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
XTLB XTL Biopharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EARS Auris Medical	N/A	N/A	N/A	N/A
MNK Mallinckrodt	N/A	N/A	N/A	N/A
OHRP OHR Pharmaceutical	N/A	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	N/A	N/A	N/A	N/A
XTLB XTL Biopharmaceuticals	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EARS Auris Medical	N/A	N/A	N/A	N/A	$1.57 per share	N/A
MNK Mallinckrodt	N/A	N/A	N/A	N/A	$47.48 per share	N/A
OHRP OHR Pharmaceutical	N/A	N/A	N/A	N/A	$3.86 per share	N/A
SXTC China SXT Pharmaceuticals	$1.97M	0.25	N/A	N/A	$32.12 per share	0.03
XTLB XTL Biopharmaceuticals	N/A	N/A	N/A	N/A	$0.73 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EARS Auris Medical	-$8.75M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MNK Mallinckrodt	N/A	-$116.19	N/A	∞	N/A	-82.59%	20.32%	2.49%	N/A
OHRP OHR Pharmaceutical	-$13.23M	N/A	0.00	∞	N/A	N/A	-75.46%	-71.18%	N/A
SXTC China SXT Pharmaceuticals	-$5.93M	N/A	0.00	∞	N/A	N/A	N/A	N/A	7/29/2024 (Estimated)
XTLB XTL Biopharmaceuticals	-$1.35M	-$0.42	N/A	∞	N/A	N/A	-73.05%	-68.83%	5/21/2024 (Estimated)

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EARS Auris Medical	N/A	N/A	N/A	N/A	N/A
MNK Mallinckrodt	N/A	N/A	N/A	N/A	N/A
OHRP OHR Pharmaceutical	N/A	N/A	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
XTLB XTL Biopharmaceuticals	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EARS Auris Medical	N/A	3.83	3.83
MNK Mallinckrodt	1.18	0.57	0.31
OHRP OHR Pharmaceutical	N/A	3.73	3.73
SXTC China SXT Pharmaceuticals	0.02	1.47	1.41
XTLB XTL Biopharmaceuticals	N/A	14.09	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
EARS Auris Medical	6.03%
MNK Mallinckrodt	83.74%
OHRP OHR Pharmaceutical	10.70%
SXTC China SXT Pharmaceuticals	5.02%
XTLB XTL Biopharmaceuticals	4.40%

Insider Ownership

Company	Insider Ownership
EARS Auris Medical	N/A
MNK Mallinckrodt	0.30%
OHRP OHR Pharmaceutical	12.50%
SXTC China SXT Pharmaceuticals	3.95%
XTLB XTL Biopharmaceuticals	29.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
EARS Auris Medical	132,200	11.42 million	N/A	Not Optionable
MNK Mallinckrodt	2,700	13.17 million	13.13 million	Not Optionable
OHRP OHR Pharmaceutical	3	2.83 million	N/A	Not Optionable
SXTC China SXT Pharmaceuticals	78	460,000	439,000	Not Optionable
XTLB XTL Biopharmaceuticals	N/A	5.45 million	3.87 million	Not Optionable

SXTC, MNK, OHRP, XTLB, and EARS Headlines

Source	Headline
	U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.03% msn.com - March 20 at 8:50 PM
	US Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top Views msn.com - March 20 at 3:48 PM
	Dow Surges 350 Points; Fed Holds Rates Steady markets.businessinsider.com - March 20 at 3:48 PM
	Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher markets.businessinsider.com - March 20 at 3:48 PM
	XTL To Aquire The Social Proxy globenewswire.com - March 20 at 10:15 AM
	XTL Biopharmaceuticals Ltd ADR (XTLB) investing.com - February 17 at 10:28 AM
	Call for Proposals raps.org - February 11 at 2:00 PM
	XTL Biopharmaceuticals Ltd (H2K2.MU) finance.yahoo.com - October 23 at 11:13 PM
	XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency finanznachrichten.de - October 23 at 12:16 AM
	XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel finanznachrichten.de - October 21 at 8:22 AM
	XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel finance.yahoo.com - October 20 at 7:35 PM
	XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency finance.yahoo.com - October 20 at 7:35 PM
	Is X T L Biopharmaceuticals Ltd (ADR) (XTLB) Stock a Good Investment? aaii.com - March 30 at 3:19 PM
	XTLB XTL Biopharmaceuticals Ltd. seekingalpha.com - October 1 at 8:47 PM
	X T L Biopharmaceuticals Ltd reuters.com - August 8 at 10:32 PM
	LIFE, TBLT and XTLB among pre market gainers seekingalpha.com - July 23 at 7:53 AM
	XTL Biopharmaceuticals Year to Date Total Returns (Daily) ycharts.com - December 18 at 11:24 PM
	XTL Biopharmaceuticals Dividend Per Share (TTM) ycharts.com - December 18 at 1:03 AM
	XTL Biopharmaceuticals Ltd. (XTLB) uk.finance.yahoo.com - December 15 at 10:18 AM
	X.T.L. Biopharmaceuticals Ltd. - ADR money.usnews.com - September 26 at 12:03 AM
	XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Up 1.8% This Year: What Should You Expect Next? stocksregister.com - August 23 at 4:44 PM
	Is XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) Expensive At $4.67? Here’s How To Know. marketingsentinel.com - August 20 at 5:09 PM
	How Is XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Expected To Fare In The Coming Months? marketingsentinel.com - July 26 at 9:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Auris Medical

NASDAQ:EARS

Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.

Mallinckrodt

NYSE:MNK

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.

OHR Pharmaceutical

NASDAQ:OHRP

OHR Pharmaceutical, Inc. operates as a development stage pharmaceutical company. The company intends to merge with NeuBase Therapeutics, Inc. that focuses on advancing NeuBase's peptide-nucleic acid antisense oligonucleotide technology platform for the development of therapies to address severe and currently untreatable diseases caused by genetic mutations. OHR Pharmaceutical, Inc. is headquartered in New York, New York.

China SXT Pharmaceuticals

NASDAQ:SXTC

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

XTL Biopharmaceuticals

NASDAQ:XTLB

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial